Open | $149.990 |
Close | $147.060 |
Volume / Avg. | 192.048K / 425.293K |
Day Range | 146.770 - 150.725 |
52 Wk Range | 64.330 - 161.000 |
Market Cap | $8.326B |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 49 |
Short Interest | 7.55% |
Days to Cover | 6.07 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Ascendis Pharma (NASDAQ: ASND) through any online brokerage.
Other companies in Ascendis Pharma’s space includes: Legend Biotech (NASDAQ:LEGN), Sarepta Therapeutics (NASDAQ:SRPT), Exact Sciences (NASDAQ:EXAS), Neurocrine Biosciences (NASDAQ:NBIX) and Karuna Therapeutics (NASDAQ:KRTX).
The latest price target for Ascendis Pharma (NASDAQ: ASND) was reported by Wells Fargo on Friday, March 15, 2024. The analyst firm set a price target for 260.00 expecting ASND to rise to within 12 months (a possible 76.80% upside). 36 analyst firms have reported ratings in the last year.
The stock price for Ascendis Pharma (NASDAQ: ASND) is $147.06 last updated March 18, 2024 at 4:00 PM EDT.
There are no upcoming dividends for Ascendis Pharma.
Ascendis Pharma’s Q1 earnings are confirmed for Thursday, April 25, 2024.
There is no upcoming split for Ascendis Pharma.
Ascendis Pharma is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.